Testing effectiveness (Phase 2)Not Yet RecruitingNCT06361979What this trial is testingSHR-A1811 Combined With Bevacizumab in HER2-positive Breast Cancer With Brain MetastasesWho this might be right forBreasr Cancer Huihua Xiong 30